Stockreport

Kymera Therapeutics to Participate in Upcoming February Investor Conferences

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral [Read more]